|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/5415 | (2006.01) |
| (11) | Number of the document | 3256138 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16750078.4 |
| Date of filing the European patent application | 2016-04-11 | |
| (97) | Date of publication of the European application | 2017-12-20 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-23 |
| (46) | Date of publication of the claims translation | 2022-06-10 |
| (86) | Number | PCT/US2016/026991 |
| Date | 2016-04-11 |
| (87) | Number | WO 2016/131067 |
| Date | 2016-08-18 |
| (30) | Number | Date | Country code |
| 201562259993 P | 2015-11-25 | US |
| (72) |
TABUTEAU, Herriot , US
|
| (73) |
Axsome Therapeutics, Inc. ,
22 Cortlandt Street, 16th Floor, New York, NY 10007,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinės kompozicijos, apimančios meloksikamą |
| PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM |
| Payment date | Validity (years) | Amount | |
| 2026-03-27 | 11 | 289.00 EUR |
| 2027-04-11 |